Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04361994

The GErman Italian Spanish Takotsubo (GEIST) Registry

GEIST is a multicenter, international observational registry of patients with Takotsubo syndrome. Data regarding the clinical profile (demographic characteristics, clinical presentation, laboratory measures, electrocardiography /echocardiography / coronary angiography parameters, treatment and medication), in-hospital course and complications and short-/long-term outcome are collected prospectively and retrospectively to increase the understanding of the disease.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Takotsubo Syndrome Cardiomyopathies Cardiovascular Diseases Heart Diseases Takotsubo Cardiomyopathy Ventricular Dysfunction Ventricular Dysfunction, Left

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Universität zu Lübeck, Lübeck, Schleswig-Holstein, Germany

Loading trial locations.

About this study

The open-ended, multicenter, international GEIST registry collects data from patients with Takotsubo syndrome during the index hospitalization and follow-up. Furthermore, long-term outcome data are acquired with structured telephone interviews, in case patients do not undergo regular outpatient visits in the participating study centers. The GEIST registry retrospectively includes data, which have already been collected, and prospectively continues to enroll patients with newly diagnosed Takotsubo syndrome.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with Takotsubo syndrome

Exclusion criteria

  • Non

Treatment and study plan

Primary outcomes

  1. All-cause mortality

    Time frame: Day 0

    All-cause mortality (in-hospital, short-term, long-term)

  2. All-cause mortality

    Time frame: 3 Month

    All-cause mortality (in-hospital, short-term, long-term)

  3. All-cause mortality

    Time frame: 6 Month

    All-cause mortality (in-hospital, short-term, long-term)

Secondary outcomes

  1. In-Hospital complications

    Time frame: Day 0

    Cardiogenic shock, pulmonary edema, death, life-threatening arrhythmias, ventricular thrombus formation, right ventricular involvement

Study contacts

Contact information is provided by the study sponsor or research team.

Ingo Eitel, Prof. Dr.

CONTACT

[email protected]

004945150044501

Thomas Stiermaier, Dr.

CONTACT

Sponsors and collaborators

Lead sponsor

Prof. Dr. med. Ingo Eitel

Other

Collaborators

  • University of Foggia

Registry information

Acronym: GEIST

Important dates

Study start
2015
Primary completion
2035
Study completion
2035
First posted
Apr 24, 2020
Registry last updated
Dec 26, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.